Cowak, Stephanie Rose D.

HRN: 21-23-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/14/2022
04/20/2022
ORAL
8ml
3x A Day
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: